ATP Assays Market by Product (Consumables (Reagents, Microplate), Instruments (Luminometer, Spectrophotometer)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, F&B, Academics) - Global Forecast to 2028
The global ATP Assays market is projected to reach USD 0.5 illion by 2028 from USD 0.3 billion in 2023, at a CAGR of 7.8% during the forecast period. Growth in the ATP assays market can primarily be attributed to factors such as the growing investments in pharmaceutical & biotechnology Research & Development, the change from culture-based tests to rapid tests, and rising prevalence of cancer and other infectious diseases. However, the survival of small players and new entrants, are expected to challenge market growth to a certain extent.
The consumables & accessories segment is projected to account for the largest share of the ATP assays market
By product, ATP assays market is segmented into consumables & accessories and instruments. The consumables & accessories segment accounted for the largest share of the ATP assays market in 2022.This prevalence can be attributed to the extensive usage of ATP assays in research institutes to evaluate cell viability, the increasing need for tumor testing and cell proliferation (particularly in cancer) due to the rise in chronic diseases, and the frequent acquisition of consumables by pharmaceutical and biotechnology companies.
Contamination Testing segment is projected to account for the largest share of the ATP assays market in 2023
By application, the ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. In 2023, the contamination testing segment is projected to account for the largest share of the ATP assays market due to the growing regulatory severity of pharmaceutical and food & beverage companies for non-contaminated production, and the necessity for cleaning and disinfection of environmental surfaces in hospitals.
By end user, Pharmaceutical & Biotechnology companies accounted for the largest share of the market in 2022
By end users, The ATP assays market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The dominance of Pharmaceutical & Biotechnology companies segment can be attributed to several significant factors. These include the presence of a substantial number of pharmaceutical players who are making significant investments in this market, the increasing regulatory approvals for cell culture-based vaccines that require the use of ATP assays in contamination testing, the expansion of commercial activities by various pharmaceutical companies, the growing demand for cell and gene therapies to combat chronic diseases.
By region, North America is projected to account for the largest share of the ATP assays market
By region,North America accounted for the largest share of the ATP assays market in 2023. Factors such as the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.
Break of primary participants was as mentioned below:
The key players operating in the ATP Assays Market include Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), Neogen Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest,Inc. (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology,Inc. (US).
Research Coverage:
The report analyzes the ATP Assays Market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application and end user. The report also includes a product portfolio matrix of various ATP Assays products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Analysis of key drivers (increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests), restraints (the high cost of instruments and inability to differentiate between extracellular and intracellular ATP),opportunities (technological enhancements in ATP Assay probes and growth prospects in emerging markets) and challenges (survival of small players and new entrants) influencing the growth of ATP Assays market.
The consumables & accessories segment is projected to account for the largest share of the ATP assays market
By product, ATP assays market is segmented into consumables & accessories and instruments. The consumables & accessories segment accounted for the largest share of the ATP assays market in 2022.This prevalence can be attributed to the extensive usage of ATP assays in research institutes to evaluate cell viability, the increasing need for tumor testing and cell proliferation (particularly in cancer) due to the rise in chronic diseases, and the frequent acquisition of consumables by pharmaceutical and biotechnology companies.
Contamination Testing segment is projected to account for the largest share of the ATP assays market in 2023
By application, the ATP assays market is segmented into contamination testing, disease testing, and drug discovery & development. In 2023, the contamination testing segment is projected to account for the largest share of the ATP assays market due to the growing regulatory severity of pharmaceutical and food & beverage companies for non-contaminated production, and the necessity for cleaning and disinfection of environmental surfaces in hospitals.
By end user, Pharmaceutical & Biotechnology companies accounted for the largest share of the market in 2022
By end users, The ATP assays market is segmented into pharmaceutical & biotechnology companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutes. The dominance of Pharmaceutical & Biotechnology companies segment can be attributed to several significant factors. These include the presence of a substantial number of pharmaceutical players who are making significant investments in this market, the increasing regulatory approvals for cell culture-based vaccines that require the use of ATP assays in contamination testing, the expansion of commercial activities by various pharmaceutical companies, the growing demand for cell and gene therapies to combat chronic diseases.
By region, North America is projected to account for the largest share of the ATP assays market
By region,North America accounted for the largest share of the ATP assays market in 2023. Factors such as the increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical & biopharmaceutical companies, increasing production of COVID-19 drugs, increasing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.
Break of primary participants was as mentioned below:
- By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
- By Designation – C-level–35%, Director-level–25%, Others–40%
- By Region – North America–45%, Asia Pacific–20%, Europe–30%, Latin America- 3%, Middle East and Africa–2%
The key players operating in the ATP Assays Market include Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Merck KGaA (Germany), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Abcam plc (UK), Lonza Group (Switzerland), Neogen Corporation (US), 3M (US), Danaher Corporation (US), PromoCell GmbH (Germany), Geno Technology, Inc. (US), Abnova Corporation (Taiwan), AAT Bioquest,Inc. (US), BioThema AB (Sweden), Elabscience Biotechnology Inc. (US), MBL International Corporation (US), Biotium (US), Creative Bioarray (US), Canvax Biotech S.L. (Spain), Ruhof Corporation (US), Charm Sciences, Inc. (US), Bio Shield Tech, LLC (US), Cayman Chemical (US), and Cell Signaling Technology,Inc. (US).
Research Coverage:
The report analyzes the ATP Assays Market and aims at estimating the market size and future growth potential of this market based on various segments such as product, application and end user. The report also includes a product portfolio matrix of various ATP Assays products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Analysis of key drivers (increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and the shift from culture-based tests to rapid tests), restraints (the high cost of instruments and inability to differentiate between extracellular and intracellular ATP),opportunities (technological enhancements in ATP Assay probes and growth prospects in emerging markets) and challenges (survival of small players and new entrants) influencing the growth of ATP Assays market.
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global ATP Assays Market. The report analyzes this market by, applications and end user.
- Service Enhancement/Innovation: Detailed insights on upcoming trends in the global ATP Assays Market
- Market Development: Comprehensive information on the lucrative emerging markets by applications, products and end user.
- Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global ATP Assays Market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, company evaluation quadrant, and capabilities of leading players in the global ATP Assays Market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 ATP ASSAYS MARKET SEGMENTATION
FIGURE 2 ATP ASSAYS MARKET: REGIONAL SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC INC.
FIGURE 10 GLOBAL ATP ASSAYS MARKET: BY PRODUCT
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 CAGR PROJECTIONS: ATP ASSAYS MARKET
FIGURE 13 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 14 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ATP ASSAYS MARKET
2.8 RECESSION IMPACT ON ATP ASSAYS MARKET
TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 4 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 5 US HEALTHCARE EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 15 ATP ASSAYS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 16 ATP ASSAYS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 17 ATP ASSAYS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF ATP ASSAYS MARKET
4 PREMIUM INSIGHTS
4.1 ATP ASSAYS MARKET OVERVIEW
FIGURE 19 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET
4.2 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2022)
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ATP ASSAYS MARKET IN 2022
4.3 ATP ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE IN ATP ASSAYS MARKET DURING FORECAST PERIOD
4.4 ATP ASSAYS MARKET, BY REGION (2023–2028)
FIGURE 22 NORTH AMERICA TO DOMINATE GLOBAL ATP ASSAYS MARKET IN 2028
4.5 ATP ASSAYS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 6 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing food safety concerns globally
5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies
5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D
FIGURE 25 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
5.2.1.4 Increasing prevalence of cancer globally
TABLE 7 ESTIMATED NEW CANCER CASES IN US, 2023
FIGURE 26 GLOBAL CANCER INCIDENCE AND MORTALITY, 2020
5.2.1.5 Shift from culture-based tests to rapid tests
5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments and reagents
5.2.2.2 Inability to differentiate between extracellular and intracellular ATP
5.2.3 OPPORTUNITIES
5.2.3.1 Technological enhancements in ATP assay probes
5.2.3.2 Growth prospects in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Low survival rate for small players and new entrants
5.3 INDUSTRY TRENDS
5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES
5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2
5.4 TECHNOLOGY ANALYSIS
5.4.1 HOMOGENEOUS TIME-RESOLVED FLUORESCENCE TECHNOLOGY FOR RAPID SCREENING OF ATP CONCENTRATIONS
5.4.2 EASE OF USE OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYZERS IN CLINICAL LABORATORIES
5.4.3 ADVANCED ASSAY STABILITY (AAS) SYSTEMS TO MATCH ROOM TEMPERATURE WHILE PERFORMING ASSAYS
5.4.4 OTHER TECHNOLOGICAL INNOVATIONS
5.5 REGULATORY ANALYSIS
5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.1.1 North America
5.5.1.1.1 US
5.5.1.1.2 Canada
5.5.1.2 Europe
5.5.1.3 Asia Pacific
5.5.1.4 Rest of the World
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–JUNE 2023)
5.6.3 LIST OF PATENTS/PATENT APPLICATIONS IN ATP ASSAYS MARKET
5.7 VALUE CHAIN ANALYSIS
FIGURE 29 ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM MARKET MAP
FIGURE 30 ATP ASSAYS MARKET: ECOSYSTEM MARKET MAP
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE, BY KEY PLAYER
TABLE 9 AVERAGE SELLING PRICE, BY KEY PLAYER
TABLE 10 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD)
5.10.2 AVERAGE SELLING PRICE TREND
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 11 ATP ASSAYS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ATP ASSAY PRODUCTS
5.12.2 BUYING CRITERIA FOR ATP ASSAYS
FIGURE 32 KEY BUYING CRITERIA FOR END USERS
6 ATP ASSAYS MARKET, BY APPLICATION
6.1 INTRODUCTION
TABLE 12 ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
6.2 CONTAMINATION TESTING
6.2.1 INCREASING REQUIREMENTS TO MEET REGULATORY MANDATES FOR QUALITY TESTING TO DRIVE MARKET
TABLE 13 ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 DISEASE TESTING
6.3.1 GROWING DISEASE INCIDENCE AND RISING PATIENT AWARENESS TO DRIVE MARKET
TABLE 14 ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 DRUG DISCOVERY & DEVELOPMENT
6.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS TO DRIVE MARKET
TABLE 15 ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7 ATP ASSAYS MARKET, BY PRODUCT
7.1 INTRODUCTION
TABLE 16 ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
7.2 CONSUMABLES & ACCESSORIES
TABLE 17 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE
TABLE 18 ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.1 REAGENTS & KITS
7.2.1.1 Growing prevalence of infectious diseases and increasing use of contamination testing to drive segment
TABLE 20 REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 MICROPLATES
7.2.2.1 Increasing demand in drug discovery and preclinical safety studies to drive segment
TABLE 21 MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.3 OTHER CONSUMABLES & ACCESSORIES
TABLE 22 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 INSTRUMENTS
TABLE 23 ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 24 ATP ASSAYS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 KEY ATP INSTRUMENTS AVAILABLE
7.3.1 LUMINOMETERS
7.3.1.1 Low cost, quick output, and ease of usage to drive segment
TABLE 26 LUMINOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2 SPECTROPHOTOMETERS
7.3.2.1 Higher cost of spectrophotometers to limit market
TABLE 27 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 ATP ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 28 ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE ATP ASSAYS END USER MARKET DURING STUDY PERIOD
TABLE 29 ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 FOOD & BEVERAGE INDUSTRY
8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION AND GROWING NEED FOR FOOD SAFETY TO DRIVE MARKET
TABLE 30 ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET
TABLE 31 ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 ACADEMIC & RESEARCH INSTITUTES
8.5.1 INCREASING USE IN CELL CULTURE EXPERIMENTS AND CANCER RESEARCH TO DRIVE MARKET
TABLE 32 ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 ATP ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 33 ATP ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 34 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 37 NORTH AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American ATP assays market during forecast period
TABLE 40 US: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 41 US: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 42 US: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 43 US: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 44 US: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Government funding programs for life science research to drive market
TABLE 45 CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 46 CANADA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 CANADA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 CANADA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 49 CANADA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 50 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 54 EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 55 EUROPE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers to drive market
TABLE 56 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 57 GERMANY: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 GERMANY: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 59 GERMANY: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 60 GERMANY: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing R&D expenditure in pharmaceutical companies and growing life science industry to drive market
FIGURE 35 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
TABLE 61 UK: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 62 UK: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 UK: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 UK: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 65 UK: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Highly profitable agro-food sector and increased focus on biotechnology R&D to drive market
TABLE 66 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 67 FRANCE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 68 FRANCE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 FRANCE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 70 FRANCE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Presence of well-developed healthcare system and high cancer burden to drive market
TABLE 71 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 72 ITALY: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 ITALY: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 ITALY: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Growth in personalized medicines and clinical diagnostics to drive market
TABLE 76 SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 SPAIN: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 78 SPAIN: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 80 SPAIN: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 81 REST OF EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 82 REST OF EUROPE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 REST OF EUROPE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 REST OF EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 85 REST OF EUROPE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 36 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT
TABLE 86 ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Increasing pharmaceutical R&D investments to drive market
TABLE 92 CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 93 CHINA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 CHINA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 96 CHINA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Higher incidence of cancer and greater geriatric population to drive market
TABLE 97 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 98 JAPAN: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 JAPAN: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 JAPAN: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Growing adoption of ATP assay techniques in research and clinical applications to drive market
TABLE 102 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 103 INDIA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 INDIA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 106 INDIA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 107 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 REST OF ASIA PACIFIC: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 REST OF ASIA PACIFIC: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 111 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 112 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 114 LATIN AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 LATIN AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 Increasing research activities and growing pharmaceutical industry to drive market
TABLE 118 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 119 BRAZIL: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 BRAZIL: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 122 BRAZIL: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Increase in research centers and manufacturing units to drive market
TABLE 123 MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 124 MEXICO: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 MEXICO: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 127 MEXICO: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 128 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 129 REST OF LATIN AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 REST OF LATIN AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 132 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING FUNDING INITIATIVES AND INCREASING STRATEGIC PARTNERSHIPS TO DRIVE MARKET
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 133 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY MAJOR PLAYERS
TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ATP ASSAYS MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN ATP ASSAYS MARKET
10.4 MARKET RANKING OF KEY PLAYERS IN ATP ASSAYS MARKET
FIGURE 38 ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2022
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 39 ATP ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 40 ATP ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
10.7 COMPANY FOOTPRINT
TABLE 139 COMPANY FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.1 PRODUCT FOOTPRINT
TABLE 140 PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.2 APPLICATION FOOTPRINT
TABLE 141 APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.3 END USER FOOTPRINT
TABLE 142 END USER FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.4 GEOGRAPHICAL FOOTPRINT
TABLE 143 REGIONAL FOOTPRINT: ATP ASSAYS MARKET (2022)
10.8 COMPETITIVE SCENARIOS AND TRENDS
10.8.1 KEY PRODUCT LAUNCHES
TABLE 144 KEY PRODUCT LAUNCHES, JANUARY 2019–JUNE 2023
10.8.2 KEY DEALS
TABLE 145 KEY DEALS, JANUARY 2019–JUNE 2023
10.8.3 OTHER KEY DEVELOPMENTS
TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2019–JUNE 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 147 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
11.1.2 MERCK KGAA
TABLE 148 MERCK KGAA: COMPANY OVERVIEW
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.3 PROMEGA CORPORATION
TABLE 149 PROMEGA CORPORATION: COMPANY OVERVIEW
11.1.4 NEOGEN CORPORATION
TABLE 150 NEOGEN CORPORATION: COMPANY OVERVIEW
FIGURE 43 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 PERKINELMER INC.
TABLE 151 PERKINELMER INC.: COMPANY OVERVIEW
FIGURE 44 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
11.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 152 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 45 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
11.1.7 PROMOCELL GMBH
TABLE 153 PROMOCELL GMBH: COMPANY OVERVIEW
11.1.8 DANAHER CORPORATION
TABLE 154 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 LONZA
TABLE 155 LONZA: COMPANY OVERVIEW
FIGURE 47 LONZA: COMPANY SNAPSHOT (2022)
11.1.10 ABCAM PLC
TABLE 156 ABCAM PLC: COMPANY OVERVIEW
FIGURE 48 ABCAM PLC: COMPANY SNAPSHOT (2022)
11.1.11 3M
TABLE 157 3M: COMPANY OVERVIEW
FIGURE 49 3M: COMPANY SNAPSHOT (2022)
11.1.12 ABNOVA CORPORATION
TABLE 158 ABNOVA CORPORATION: COMPANY OVERVIEW
11.1.13 GENO TECHNOLOGY INC.
TABLE 159 GENO TECHNOLOGY INC.: COMPANY OVERVIEW
11.1.14 AAT BIOQUEST, INC.
TABLE 160 AAT BIOQUEST, INC.: COMPANY OVERVIEW
11.1.15 BIOTHEMA AB
TABLE 161 BIOTHEMA AB: COMPANY OVERVIEW
11.1.16 BIOTIUM
TABLE 162 BIOTIUM: COMPANY OVERVIEW
11.1.17 CREATIVE BIOARRAY
TABLE 163 CREATIVE BIOARRAY: COMPANY OVERVIEW
11.1.18 CANVAX
TABLE 164 CANVAX: COMPANY OVERVIEW
11.1.19 ELABSCIENCE BIOTECHNOLOGY INC.
TABLE 165 ELABSCIENCE BIOTECHNOLOGY INC.: COMPANY OVERVIEW
11.1.20 MBL INTERNATIONAL CORPORATION
TABLE 166 MBL INTERNATIONAL CORPORATION: COMPANY OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 RUHOF CORPORATION
11.2.2 CHARM SCIENCES
11.2.3 BIO SHIELD TECH, LLC
11.2.4 CAYMAN CHEMICAL
11.2.5 CELL SIGNALING TECHNOLOGY, INC.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION AND SCOPE
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 ATP ASSAYS MARKET SEGMENTATION
FIGURE 2 ATP ASSAYS MARKET: REGIONAL SEGMENTATION
1.2.3 YEARS CONSIDERED
1.3 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 8 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC INC.
FIGURE 10 GLOBAL ATP ASSAYS MARKET: BY PRODUCT
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 CAGR PROJECTIONS: ATP ASSAYS MARKET
FIGURE 13 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 14 DATA TRIANGULATION METHODOLOGY
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: ATP ASSAYS MARKET
2.8 RECESSION IMPACT ON ATP ASSAYS MARKET
TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
TABLE 4 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 5 US HEALTHCARE EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 15 ATP ASSAYS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 16 ATP ASSAYS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 17 ATP ASSAYS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF ATP ASSAYS MARKET
4 PREMIUM INSIGHTS
4.1 ATP ASSAYS MARKET OVERVIEW
FIGURE 19 INCREASING FOOD SAFETY CONCERNS TO DRIVE MARKET
4.2 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER AND COUNTRY (2022)
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ATP ASSAYS MARKET IN 2022
4.3 ATP ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE IN ATP ASSAYS MARKET DURING FORECAST PERIOD
4.4 ATP ASSAYS MARKET, BY REGION (2023–2028)
FIGURE 22 NORTH AMERICA TO DOMINATE GLOBAL ATP ASSAYS MARKET IN 2028
4.5 ATP ASSAYS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 6 ATP ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing food safety concerns globally
5.2.1.2 Growing demand for ATP assays in pharmaceutical & biotechnology companies
5.2.1.3 Rising investments in pharmaceutical & biotechnology R&D
FIGURE 25 GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
5.2.1.4 Increasing prevalence of cancer globally
TABLE 7 ESTIMATED NEW CANCER CASES IN US, 2023
FIGURE 26 GLOBAL CANCER INCIDENCE AND MORTALITY, 2020
5.2.1.5 Shift from culture-based tests to rapid tests
5.2.1.6 Rising incidence and prevalence of chronic and infectious diseases
5.2.2 RESTRAINTS
5.2.2.1 High cost of instruments and reagents
5.2.2.2 Inability to differentiate between extracellular and intracellular ATP
5.2.3 OPPORTUNITIES
5.2.3.1 Technological enhancements in ATP assay probes
5.2.3.2 Growth prospects in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Low survival rate for small players and new entrants
5.3 INDUSTRY TRENDS
5.3.1 INCREASING REGULATIONS FOR FOOD BUSINESSES
5.3.2 ADOPTION OF ATP TESTING FOR MONITORING ENVIRONMENTAL CONTAMINATION CAUSED BY SARS-COV-2
5.4 TECHNOLOGY ANALYSIS
5.4.1 HOMOGENEOUS TIME-RESOLVED FLUORESCENCE TECHNOLOGY FOR RAPID SCREENING OF ATP CONCENTRATIONS
5.4.2 EASE OF USE OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ANALYZERS IN CLINICAL LABORATORIES
5.4.3 ADVANCED ASSAY STABILITY (AAS) SYSTEMS TO MATCH ROOM TEMPERATURE WHILE PERFORMING ASSAYS
5.4.4 OTHER TECHNOLOGICAL INNOVATIONS
5.5 REGULATORY ANALYSIS
5.5.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.5.1.1 North America
5.5.1.1.1 US
5.5.1.1.2 Canada
5.5.1.2 Europe
5.5.1.3 Asia Pacific
5.5.1.4 Rest of the World
5.6 PATENT ANALYSIS
5.6.1 PATENT PUBLICATION TRENDS FOR ATP ASSAYS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011–JUNE 2023)
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ATP ASSAY PATENTS (JANUARY 2011–JUNE 2023)
5.6.3 LIST OF PATENTS/PATENT APPLICATIONS IN ATP ASSAYS MARKET
5.7 VALUE CHAIN ANALYSIS
FIGURE 29 ATP ASSAYS MARKET: VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM MARKET MAP
FIGURE 30 ATP ASSAYS MARKET: ECOSYSTEM MARKET MAP
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 ATP ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE, BY KEY PLAYER
TABLE 9 AVERAGE SELLING PRICE, BY KEY PLAYER
TABLE 10 REGIONAL PRICING ANALYSIS OF ATP ASSAYS, 2021 (USD)
5.10.2 AVERAGE SELLING PRICE TREND
5.11 KEY CONFERENCES AND EVENTS IN 2023–2024
TABLE 11 ATP ASSAYS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ATP ASSAY PRODUCTS
5.12.2 BUYING CRITERIA FOR ATP ASSAYS
FIGURE 32 KEY BUYING CRITERIA FOR END USERS
6 ATP ASSAYS MARKET, BY APPLICATION
6.1 INTRODUCTION
TABLE 12 ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
6.2 CONTAMINATION TESTING
6.2.1 INCREASING REQUIREMENTS TO MEET REGULATORY MANDATES FOR QUALITY TESTING TO DRIVE MARKET
TABLE 13 ATP ASSAYS MARKET FOR CONTAMINATION TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 DISEASE TESTING
6.3.1 GROWING DISEASE INCIDENCE AND RISING PATIENT AWARENESS TO DRIVE MARKET
TABLE 14 ATP ASSAYS MARKET FOR DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 DRUG DISCOVERY & DEVELOPMENT
6.4.1 INCREASING R&D PIPELINE FOR PHARMACEUTICAL DRUGS TO DRIVE MARKET
TABLE 15 ATP ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
7 ATP ASSAYS MARKET, BY PRODUCT
7.1 INTRODUCTION
TABLE 16 ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
7.2 CONSUMABLES & ACCESSORIES
TABLE 17 KEY ATP CONSUMABLES & ACCESSORIES AVAILABLE
TABLE 18 ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.1 REAGENTS & KITS
7.2.1.1 Growing prevalence of infectious diseases and increasing use of contamination testing to drive segment
TABLE 20 REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.2 MICROPLATES
7.2.2.1 Increasing demand in drug discovery and preclinical safety studies to drive segment
TABLE 21 MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.2.3 OTHER CONSUMABLES & ACCESSORIES
TABLE 22 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 INSTRUMENTS
TABLE 23 ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 24 ATP ASSAYS MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 KEY ATP INSTRUMENTS AVAILABLE
7.3.1 LUMINOMETERS
7.3.1.1 Low cost, quick output, and ease of usage to drive segment
TABLE 26 LUMINOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3.2 SPECTROPHOTOMETERS
7.3.2.1 Higher cost of spectrophotometers to limit market
TABLE 27 SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 ATP ASSAYS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 28 ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE ATP ASSAYS END USER MARKET DURING STUDY PERIOD
TABLE 29 ATP ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 FOOD & BEVERAGE INDUSTRY
8.3.1 RISING INCIDENCE OF FOOD CONTAMINATION AND GROWING NEED FOR FOOD SAFETY TO DRIVE MARKET
TABLE 30 ATP ASSAYS MARKET FOR FOOD & BEVERAGE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
8.4.1 GROWING DEMAND FOR EARLY DISEASE DIAGNOSIS TO DRIVE MARKET
TABLE 31 ATP ASSAYS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.5 ACADEMIC & RESEARCH INSTITUTES
8.5.1 INCREASING USE IN CELL CULTURE EXPERIMENTS AND CANCER RESEARCH TO DRIVE MARKET
TABLE 32 ATP ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 ATP ASSAYS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 33 ATP ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 34 NORTH AMERICA: ATP ASSAYS MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 37 NORTH AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 US
9.2.2.1 US to dominate North American ATP assays market during forecast period
TABLE 40 US: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 41 US: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 42 US: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 43 US: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 44 US: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.3 CANADA
9.2.3.1 Government funding programs for life science research to drive market
TABLE 45 CANADA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 46 CANADA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 CANADA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 CANADA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 49 CANADA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
9.3.1 EUROPE: RECESSION IMPACT
TABLE 50 EUROPE: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 54 EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 55 EUROPE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 GERMANY
9.3.2.1 Large-scale outsourcing of clinical diagnostic testing by hospitals to commercial service providers to drive market
TABLE 56 GERMANY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 57 GERMANY: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 GERMANY: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 59 GERMANY: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 60 GERMANY: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing R&D expenditure in pharmaceutical companies and growing life science industry to drive market
FIGURE 35 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)
TABLE 61 UK: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 62 UK: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 UK: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 UK: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 65 UK: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 FRANCE
9.3.4.1 Highly profitable agro-food sector and increased focus on biotechnology R&D to drive market
TABLE 66 FRANCE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 67 FRANCE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 68 FRANCE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 FRANCE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 70 FRANCE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 ITALY
9.3.5.1 Presence of well-developed healthcare system and high cancer burden to drive market
TABLE 71 ITALY: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 72 ITALY: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 73 ITALY: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 ITALY: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 ITALY: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 SPAIN
9.3.6.1 Growth in personalized medicines and clinical diagnostics to drive market
TABLE 76 SPAIN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 SPAIN: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 78 SPAIN: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 SPAIN: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 80 SPAIN: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
TABLE 81 REST OF EUROPE: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 82 REST OF EUROPE: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 REST OF EUROPE: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 REST OF EUROPE: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 85 REST OF EUROPE: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 36 ASIA PACIFIC: ATP ASSAYS MARKET SNAPSHOT
TABLE 86 ASIA PACIFIC: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 ASIA PACIFIC: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 91 ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Increasing pharmaceutical R&D investments to drive market
TABLE 92 CHINA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 93 CHINA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 94 CHINA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 CHINA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 96 CHINA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 JAPAN
9.4.3.1 Higher incidence of cancer and greater geriatric population to drive market
TABLE 97 JAPAN: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 98 JAPAN: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 99 JAPAN: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 JAPAN: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 JAPAN: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 INDIA
9.4.4.1 Growing adoption of ATP assay techniques in research and clinical applications to drive market
TABLE 102 INDIA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 103 INDIA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 INDIA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 INDIA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 106 INDIA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 107 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 REST OF ASIA PACIFIC: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 REST OF ASIA PACIFIC: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 111 REST OF ASIA PACIFIC: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 112 LATIN AMERICA: ATP ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 113 LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 114 LATIN AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 LATIN AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.2 BRAZIL
9.5.2.1 Increasing research activities and growing pharmaceutical industry to drive market
TABLE 118 BRAZIL: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 119 BRAZIL: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 BRAZIL: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 BRAZIL: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 122 BRAZIL: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.3 MEXICO
9.5.3.1 Increase in research centers and manufacturing units to drive market
TABLE 123 MEXICO: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 124 MEXICO: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 MEXICO: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 MEXICO: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 127 MEXICO: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.4 REST OF LATIN AMERICA
TABLE 128 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 129 REST OF LATIN AMERICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 REST OF LATIN AMERICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 132 REST OF LATIN AMERICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING FUNDING INITIATIVES AND INCREASING STRATEGIC PARTNERSHIPS TO DRIVE MARKET
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 133 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: ATP ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY MAJOR PLAYERS
TABLE 138 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ATP ASSAYS MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN ATP ASSAYS MARKET
10.4 MARKET RANKING OF KEY PLAYERS IN ATP ASSAYS MARKET
FIGURE 38 ATP ASSAYS MARKET RANKING, BY KEY PLAYER, 2022
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 39 ATP ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 40 ATP ASSAYS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
10.7 COMPANY FOOTPRINT
TABLE 139 COMPANY FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.1 PRODUCT FOOTPRINT
TABLE 140 PRODUCT FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.2 APPLICATION FOOTPRINT
TABLE 141 APPLICATION FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.3 END USER FOOTPRINT
TABLE 142 END USER FOOTPRINT: ATP ASSAYS MARKET (2022)
10.7.4 GEOGRAPHICAL FOOTPRINT
TABLE 143 REGIONAL FOOTPRINT: ATP ASSAYS MARKET (2022)
10.8 COMPETITIVE SCENARIOS AND TRENDS
10.8.1 KEY PRODUCT LAUNCHES
TABLE 144 KEY PRODUCT LAUNCHES, JANUARY 2019–JUNE 2023
10.8.2 KEY DEALS
TABLE 145 KEY DEALS, JANUARY 2019–JUNE 2023
10.8.3 OTHER KEY DEVELOPMENTS
TABLE 146 OTHER KEY DEVELOPMENTS, JANUARY 2019–JUNE 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 147 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
11.1.2 MERCK KGAA
TABLE 148 MERCK KGAA: COMPANY OVERVIEW
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.3 PROMEGA CORPORATION
TABLE 149 PROMEGA CORPORATION: COMPANY OVERVIEW
11.1.4 NEOGEN CORPORATION
TABLE 150 NEOGEN CORPORATION: COMPANY OVERVIEW
FIGURE 43 NEOGEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 PERKINELMER INC.
TABLE 151 PERKINELMER INC.: COMPANY OVERVIEW
FIGURE 44 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
11.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 152 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 45 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
11.1.7 PROMOCELL GMBH
TABLE 153 PROMOCELL GMBH: COMPANY OVERVIEW
11.1.8 DANAHER CORPORATION
TABLE 154 DANAHER CORPORATION: COMPANY OVERVIEW
FIGURE 46 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 LONZA
TABLE 155 LONZA: COMPANY OVERVIEW
FIGURE 47 LONZA: COMPANY SNAPSHOT (2022)
11.1.10 ABCAM PLC
TABLE 156 ABCAM PLC: COMPANY OVERVIEW
FIGURE 48 ABCAM PLC: COMPANY SNAPSHOT (2022)
11.1.11 3M
TABLE 157 3M: COMPANY OVERVIEW
FIGURE 49 3M: COMPANY SNAPSHOT (2022)
11.1.12 ABNOVA CORPORATION
TABLE 158 ABNOVA CORPORATION: COMPANY OVERVIEW
11.1.13 GENO TECHNOLOGY INC.
TABLE 159 GENO TECHNOLOGY INC.: COMPANY OVERVIEW
11.1.14 AAT BIOQUEST, INC.
TABLE 160 AAT BIOQUEST, INC.: COMPANY OVERVIEW
11.1.15 BIOTHEMA AB
TABLE 161 BIOTHEMA AB: COMPANY OVERVIEW
11.1.16 BIOTIUM
TABLE 162 BIOTIUM: COMPANY OVERVIEW
11.1.17 CREATIVE BIOARRAY
TABLE 163 CREATIVE BIOARRAY: COMPANY OVERVIEW
11.1.18 CANVAX
TABLE 164 CANVAX: COMPANY OVERVIEW
11.1.19 ELABSCIENCE BIOTECHNOLOGY INC.
TABLE 165 ELABSCIENCE BIOTECHNOLOGY INC.: COMPANY OVERVIEW
11.1.20 MBL INTERNATIONAL CORPORATION
TABLE 166 MBL INTERNATIONAL CORPORATION: COMPANY OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 RUHOF CORPORATION
11.2.2 CHARM SCIENCES
11.2.3 BIO SHIELD TECH, LLC
11.2.4 CAYMAN CHEMICAL
11.2.5 CELL SIGNALING TECHNOLOGY, INC.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 CUSTOMIZATION OPTIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
